Development of a Hypoxia-Triggered Supramolecular Nanoplatform for Synergistic Hypoxia Alleviation and Amplified Photodynamic Cancer Therapy
Molecules · 11.07.2026 · 31 (14) · 2433
DOI: 10.3390/molecules31142433 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, online erschienen am 11.07.2026. Verfasst von Ningning Luo und 8 weiteren Autor:innen. Beteiligte Einrichtung: Jiangsu Province Key Laboratory for Inflammation and Molecular Drug Target, School of Pharmacy, Nantong University, Nantong 226001, China. Hauptthemen laut MEDLINE: Photochemotherapy, Photosensitizing Agents, Nanoparticles, Hypoxia. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Key Natural Science Foundation of Jiangsu Higher Education Institutions, Postgraduate Research & Practice Innovation Program of Jiangsu Province.
Abstract (Originalsprache)
Photodynamic therapy (PDT) represents a highly promising modality for cancer treatment; however, its clinical success is significantly restricted by the hypoxic nature of the tumor microenvironment (TME). Hypoxia also upregulates hypoxia-inducible factor-1α (HIF-1α) expression, thereby exacerbating tumor malignancy. To tackle this challenge, we engineered a hypoxia-activatable supramolecular nanoplatform (GH@CyNPs) capable of dual hypoxia reversal and amplification of PDT efficacy. The nanoplatform was constructed via host–guest interactions between a water-soluble pillar[5]arene (WP5) and an azobenzene-linked cyanine/YC-1 conjugate (Cy-G), followed by the co-encapsulation of glucose oxidase (GOx) and catalase (CAT). Upon entering the cancer cells via endocytosis, the azobenzene linker is specifically cleaved by the hypoxic TME, facilitating payload release. Concurrently, the released GOx/CAT pair drives in situ cascade reactions to generate oxygen (O2), while YC-1 effectively suppresses HIF-1α expression, thereby achieving synergistic alleviation of hypoxia. Under irradiation, the released cyanine acts as a potent photosensitizer, generating abundant reactive oxygen species (ROS) to kill cancer cells. Both in vitro and in vivo evaluations corroborated that GH@CyNPs exhibit preferential tumor accumulation, profound antitumor efficacy, and excellent biocompatibility. This study presents an innovative paradigm for overcoming TME hypoxia to optimize photodynamic oncotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Jiangsu Province Key Laboratory for Inflammation and Molecular Drug Target, School of Pharmacy, Nantong University, Nantong 226001, China.
- Jiangsu Key Laboratory of Molecular Medicine, Medical School of Nanjing University, Nanjing 210093, China.
Förderung
- National Natural Science Foundation of China
- Key Natural Science Foundation of Jiangsu Higher Education Institutions
- Postgraduate Research & Practice Innovation Program of Jiangsu Province
- the large instruments open foundation of Nantong University
- large instruments open foundation of Nantong University
Zitieren
APA
Luo, N., Wu, Y., Zheng, J., Zhang, C., Qian, X., Ji, C., Jiang, A., Ling, Y., & Liu, X. (2026). Development of a Hypoxia-Triggered Supramolecular Nanoplatform for Synergistic Hypoxia Alleviation and Amplified Photodynamic Cancer Therapy. Molecules, 31(14), 2433. https://doi.org/10.3390/molecules31142433
Vancouver
Luo N, Wu Y, Zheng J, Zhang C, Qian X, Ji C, et al. Development of a Hypoxia-Triggered Supramolecular Nanoplatform for Synergistic Hypoxia Alleviation and Amplified Photodynamic Cancer Therapy. Molecules. 2026;31(14):2433. doi:10.3390/molecules31142433
BibTeX
@article{Luo2026,
author = {Luo, Ningning and Wu, Yiliang and Zheng, Jiaxin and Zhang, Chi and Qian, Xiaoyang and Ji, Caoqing and Jiang, Aiqing and Ling, Yong and Liu, Xin},
title = {Development of a Hypoxia-Triggered Supramolecular Nanoplatform for Synergistic Hypoxia Alleviation and Amplified Photodynamic Cancer Therapy},
journal = {Molecules},
year = {2026},
volume = {31},
number = {14},
pages = {2433},
doi = {10.3390/molecules31142433}
}
EUVIMED